Hydrogen Sulfide in Renal Physiology and Disease

Antioxidants and Redox Signaling

Volumn 25, Issue 13, 2016, Pages 720-731

  Feliers, Denis ^a   Lee, Hak Joo ^a,b   Kasinath, Balakuntalam S ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Acute kidney injury; Chronic kidney disease; Diabetic kidney disease; Hypertension; Renal physiology

Indexed keywords

CISPLATIN; DOXORUBICIN; HYDROGEN SULFIDE; NITRIC OXIDE;

ACUTE KIDNEY FAILURE; DIABETIC NEPHROPATHY; GLOMERULUS FILTRATION; HUMAN; HYDRATION; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; NEPHROTOXICITY; NONHUMAN; OBSTRUCTIVE KIDNEY INJURY; PREECLAMPSIA; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SODIUM ABSORPTION; ANIMAL; KIDNEY; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; HYDROGEN SULFIDE; KIDNEY; KIDNEY DISEASES; NITRIC OXIDE; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84992709763     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2015.6596     Document Type: Review

References (106)

1. Agné AM, Baldin J-P, Benjamin AR, Orogo-Wenn MC, Wichmann L, Olson KR, Walters DV, and Althaus M. Hydrogen sulfide decreases β-adrenergic agoniststimulated lung liquid clearance by inhibiting ENaCmediated transepithelial sodium absorption. Am J Physiol Regul Integr Comp Physiol 308: R636-R649, 2015.
2. Ahangarpour A, Abdollahzade Fard A, Gharibnaseri MK, Jalali T, and Rashidi I. Hydrogen sulfide ameliorates the kidney dysfunction and damage in cisplatin-induced nephrotoxicity in rat. Vet Res Forum 5: 121-127, 2014.
3. Al-Magableh MR, Kemp-Harper BK, and Hart JL. Hydrogen sulfide treatment reduces blood pressure and oxidative stress in angiotensin II-induced hypertensive mice. Hypertens Res 38: 13-20, 2015.
4. Aminzadeh MA and Vaziri ND. Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease. Nephrol Dial Transplant 27: 498-504, 2012.
5. Azizi F, Seifi B, Kadkhodaee M, and Ahghari P. Administration of hydrogen sulfide protects ischemia reperfusion-induced acute kidney injury by reducing the oxidative stress. Ir J Med Sci 2015. Doi: 10.1007/s11845-015-1328-z.
6. Bonventre JV and Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 121: 4210-4221, 2011.
7. Bos EM, Wang R, Snijder PM, Boersema M, Damman J, Fu M, Moser J, Hillebrands J-L, Ploeg RJ, Yang G, Leuvenink HGD, and van Goor H. Cystathionine γ-lyase protects against renal ischemia/reperfusion by modulating oxidative stress. J Am Soc Nephrol 24: 759-770, 2013.
8. Boulpaep EL. The microcirculation. In: Medical Physiology a Cellular and Molecular Approach, edited by Boron WF, Boulpaep EL. Philadelphia: Saunders, 2009, pp. 482-503.
9. Branzoli U and Massey V. Evidence for an active site persulfide residue in rabbit liver aldehyde oxidase. J Biol Chem 249: 4346-4349, 1974.
10. Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, Kevil CG, and Lefer DJ. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 105: 365-374, 2009.
11. Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost 81: 165-176, 1999.
12. Chang L, Geng B, Yu F, Zhao J, Jiang H, Du J, and Tang C. Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats. Amino Acids 34: 573-585, 2008.
13. Chiku T, Padovani D, Zhu W, Singh S, Vitvitsky V, and Banerjee R. H2S biogenesis by human cystathionine gamma-lyase leads to the novel sulfur metabolites lanthionine and homolanthionine and is responsive to the grade of hyperhomocysteinemia. J Biol Chem 284: 11601-11612, 2009.
14. Coletta Francescato Della H, Cunha FQ, Costa RS, Barbosa Júnior F, Boim MA, Arnoni CP, da Silva CGA, and Coimbra TM. Inhibition of hydrogen sulphide formation reduces cisplatin-induced renal damage. Nephrol Dial Transplant 26: 479-488, 2011.
15. d'Emmanuele di Villa Bianca R, Mitidieri E, Donnarumma E, Tramontano T, Brancaleone V, Cirino G, Bucci M, and Sorrentino R. Hydrogen sulfide is involved in dexamethasone-induced hypertension in rat. Nitric Oxide 46: 80-86, 2015.
16. Do1ȩgowska B, Blogowski W, and Domański L. Clinical evidence of the association between serum perioperative changes in xanthine metabolizing enzymes activity and early post-transplant kidney allograft function. J Am Coll Surg 211: 587-595, 2010.
17. Dutta M, Biswas UK, Chakraborty R, Banerjee P, Raychaudhuri U, and Kumar A. Evaluation of plasma H2S levels and H2S synthesis in streptozotocin induced Type-2 diabetes-an experimental study based on Swietenia macrophylla seeds. Asian Pac J Trop Biomed 4: S483-S487, 2014.
18. Eid AA, Ford BM, Block K, Kasinath BS, Gorin Y, Ghosh Choudhury G, Barnes JL, and Abboud HE. AMPactivated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes. J Biol Chem 285: 37503-37512, 2010.
19. Eiland E, Nzerue C, and Faulkner M. Preeclampsia 2012. J Pregnancy 2012: 586578-7, 2012.
20. Fang L, Radovits T, Szabó G, Mózes MM, Rosivall L, and Kökény G. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3",5" guanosine monophosphate (cGMP) level in podocytes. Nephrol Dial Transplant 28: 1751-1761, 2013.
21. Feliers D, Duraisamy S, Faulkner JL, Duch J, Lee AV, Abboud HE, Choudhury GG, and Kasinath BS. Activation of renal signaling pathways in db/db mice with type 2 diabetes. Kidney Int 60: 495-504, 2001.
22. Francescato HDC, Marin ECS, Cunha Fde Q, Costa RS, Silva CGAD, and Coimbra TM. Role of endogenous hydrogen sulfide on renal damage induced by adriamycin injection. Arch Toxicol 85: 1597-1606, 2011.
23. Ganster F, Burban M, la Bourdonnaye de M, Fizanne L, Douay O, Loufrani L, Mercat A, Calès P, Radermacher P, Henrion D, Asfar P, and Meziani F. Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats. Crit Care 14: R165, 2010.
24. Giebisch G and Windhager E. Glomerular filtration and renal blood flow. In: Medical Physiology: A Cellular and Molecular Approach, edited by Boron WF, Boulpaep EL. Philadelphia: Saunders, 2009, pp. 767-781.
25. Gorin Y, Cavaglieri RC, Khazim K, Lee D-Y, Bruno F, Thakur S, Fanti P, Szyndralewiez C, Barnes JL, Block K, and Abboud HE. Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes. Am J Physiol Renal Physiol 308: F1276-F1287, 2015.
26. Han SJ, Kim JI, Park J-W, and Park KM. Hydrogen sulfide accelerates the recovery of kidney tubules after renal ischemia/reperfusion injury. Nephrol Dial Transplant 30: 1497-1506, 2015.
27. Han W, Dong Z, Dimitropoulou C, and Su Y. Hydrogen sulfide ameliorates tobacco smoke-induced oxidative stress and emphysema in mice. Antioxid Redox Signal 15: 2121-2134, 2011.
28. Hargrove JL, Trotter JF, Ashline HC, and Krishnamurti PV. Experimental diabetes increases the formation of sulfane by transsulfuration and inactivation of tyrosine aminotransferase in cytosols from rat liver. Metab Clin Exp 38: 666-672, 1989.
29. Hargrove JL. Persulfide generated from L-cysteine inactivates tyrosine aminotransferase. Requirement for a protein with cysteine oxidase activity and gamma-cystathionase. J Biol Chem 263: 17262-17269, 1988.
30. Hine C, Harputlugil E, Zhang Y, Ruckenstuhl C, Lee BC, Brace L, Longchamp A, Treviño-Villarreal JH, Mejia P, Ozaki CK, Wang R, Gladyshev VN, Madeo F, Mair WB, and Mitchell JR. Endogenous hydrogen sulfide production is essential for dietary restriction benefits. Cell 160: 132-144, 2015.
31. Holwerda KM, Burke SD, Faas MM, Zsengeller Z, Stillman IE, Kang PM, van Goor H, McCurley A, Jaffe IZ, Karumanchi SA, and Lely AT. Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor. J Am Soc Nephrol 25: 717-725, 2014.
32. Holz MK, Ballif BA, Gygi SP, and Blenis J. mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123: 569-580, 2005.
33. Huang P, Chen S, Wang Y, Liu J, Yao Q, Huang Y, Li H, Zhu M, Wang S, Li L, Tang C, Tao Y, Yang G, Du J, and Jin H. Down-regulated CBS/H2S pathway is involved in high-salt-induced hypertension in Dahl rats. Nitric Oxide 46: 192-203, 2015.
34. Jager A, Kostense PJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Donker AJ, and Stehouwer CD. Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study. Arterioscler Thromb Vasc Biol 21: 74-81, 2001.
35. Jain SK, Bull R, Rains JL, Bass PF, Levine SN, Reddy S, McVie R, and Bocchini JA. Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation? Antioxid Redox Signal 12: 1333-1337, 2010.
36. Jha JC, Gray SP, Barit D, Okabe J, El-Osta A, Namikoshi T, Thallas-Bonke V, Wingler K, Szyndralewiez C, Heitz F, Touyz RM, Cooper ME, Schmidt HHHW, and Jandeleit-Dahm KA. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. J Am Soc Nephrol 25: 1237-1254, 2014.
37. Ji W, Liu S, Dai J, Yang T, Jiang X, Duan X, and Wu Y. Hydrogen sulfide defends against the cardiovascular risk of Nw-nitro-L-argininemethyl ester-induced hypertension in rats via the nitric oxide/endothelial nitric oxide synthase pathway. Chin Med J 127: 3751-3757, 2014.
38. Kabil O and Banerjee R. Enzymology of H2S biogenesis, decay and signaling. Antioxid Redox Signal 20: 770-782, 2014.
39. Kamat PK, Kalani A, Givvimani S, Sathnur PB, Tyagi SC, and Tyagi N. Hydrogen sulfide attenuates neurodegeneration and neurovascular dysfunction induced by intracerebral-administered homocysteine in mice. Neuroscience 252: 302-319, 2013.
40. Kamat PK, Kalani A, Tyagi SC, and Tyagi N. Hydrogen sulfide epigenetically attenuates homocysteine-induced mitochondrial toxicity mediated through NMDA receptor in mouse brain endothelial (bEnd3) cells. J Cell Physiol 230: 378-394, 2015.
41. Kasinath BS, Feliers D, Sataranatarajan K, Ghosh Choudhury G, Lee M-J, and Mariappan MM. Regulation of mRNA translation in renal physiology and disease. Am J Physiol Renal Physiol 297: F1153-F1165, 2009.
42. Kimura N, Kimura H, Takahashi N, Hamada T, Maegawa H, Mori M, Imamura Y, Kusaka Y, Yoshida H, and Iwano M. Renal resistive index correlates with peritubular capillary loss and arteriosclerosis in biopsy tissues from patients with chronic kidney disease. Clin Exp Nephrol 19: 1114-1119, 2015.
43. Kimura Y and Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J 18: 1165-1167, 2004.
44. Köhn C, Dubrovska G, Huang Y, and Gollasch M. Hydrogen sulfide: potent regulator of vascular tone and stimulator of angiogenesis. Int J Biomed Sci 8: 81-86, 2012.
45. Krishnan N, Fu C, Pappin DJ, and Tonks NK. H2SInduced sulfhydration of the phosphatase PTP1B and its role in the endoplasmic reticulum stress response. Sci Signal 4: ra86, 2011.
46. Kundu S, Pushpakumar S, and Sen U. MMP-9- and NMDA receptor-mediated mechanism of diabetic renovascular remodeling and kidney dysfunction: hydrogen sulfide is a key modulator. Nitric Oxide 46: 172-185, 2015.
47. Kundu S, Pushpakumar SB, Tyagi A, Coley D, and Sen U. Hydrogen sulfide deficiency and diabetic renal remodeling: role of matrix metalloproteinase-9. Am J Physiol Endocrinol Metab 304: E1365-E1378, 2013.
48. Lee HJ, Feliers D, Mariappan MM, Sataranatarajan K, Choudhury GG, Gorin Y, and Kasinath BS. Tadalafil integrates nitric oxide-hydrogen sulfide signaling to inhibit high glucose-induced matrix protein synthesis in podocytes. J Biol Chem 290: 12014-12026, 2015.
49. Lee HJ, Mariappan MM, Feliers D, Cavaglieri RC, Sataranatarajan K, Abboud HE, Choudhury GG, and Kasinath BS. Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating AMP-activated protein kinase in renal epithelial cells. J Biol Chem 287: 4451-4461, 2012.
50. Lee M-J, Feliers D, Mariappan MM, Sataranatarajan K, Mahimainathan L, Musi N, Foretz M, Viollet B, Weinberg JM, Choudhury GG, and Kasinath BS. A role for AMPactivated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol 292: F617-F627, 2007.
51. Lee VWS and Harris DCH. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis. Nephrology (Carlton) 16: 30-38, 2011.
52. Li H, Feng S-J, Zhang G-Z, and Wang S-X. Correlation of lower concentrations of hydrogen sulfide with atherosclerosis in chronic hemodialysis patients with diabetic nephropathy. Blood Purif 38: 188-194, 2014.
53. Li J-J, Li Q, Du H-P, Wang Y-L, You S-J, Wang F, Xu XS, Cheng J, Cao Y-J, Liu C-F, and Hu L-F. Homocysteine triggers inflammatory responses in macrophages through inhibiting CSE-H2S signaling via DNA hypermethylation of CSE promoter. Int J Mol Sci 16: 12560-12577, 2015.
54. Liu L, Cui J, Song C-J, Bian J-S, Sparatore A, Soldato PD, Wang X-Y, and Yan C-D. H2S-releasing aspirin protects against aspirin-induced gastric injury via reducing oxidative stress. PLoS One 7: e46301, 2012.
55. Lobb I, Davison M, Carter D, Liu W, Haig A, Gunaratnam L, and Sener A. Hydrogen sulfide treatment mitigates renal allograft ischemia-reperfusion injury during cold storage and improves early transplant kidney function and survival following allogeneic renal transplantation. J Urol 2015. Doi: 10.1016/j.juro.2015.07.096.
56. Lobb I, Zhu J, Liu W, Haig A, Lan Z, and Sener A. Hydrogen sulfide treatment ameliorates long-term renal dysfunction resulting from prolonged warm renal ischemia-reperfusion injury. Can Urol Assoc J 8: E413-E418, 2014.
57. Mariappan MM, D'Silva K, Lee M-J, Sataranatarajan K, Barnes JL, Choudhury GG, and Kasinath BS. Ribosomal biogenesis induction by high glucose requires activation of upstream binding factor in kidney glomerular epithelial cells. Am J Physiol Renal Physiol 300: F219-F230, 2011.
58. Mariappan MM, Feliers D, Mummidi S, Choudhury GG, and Kasinath BS. High glucose, high insulin, and their combination rapidly induce laminin-beta1 synthesis by regulation of mRNA translation in renal epithelial cells. Diabetes 56: 476-485, 2007.
59. Mariappan MM, Shetty M, Sataranatarajan K, Choudhury GG, and Kasinath BS. Glycogen synthase kinase 3beta is a novel regulator of high glucose- and high insulin-induced extracellular matrix protein synthesis in renal proximal tubular epithelial cells. J Biol Chem 283: 30566-30575, 2008.
60. Massey V and Edmondson D. On the mechanism of inactivation of xanthine oxidase by cyanide. J Biol Chem 245: 6595-6598, 1970.
61. Maynard SE, Min J-Y, Merchan J, Lim K-H, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, and Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649-658, 2003.
62. Miller JW, Nadeau MR, Smith D, and Selhub J. Vitamin B-6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats. Am J Clin Nutr 59: 1033-1039, 1994.
63. Mise K, Hoshino J, Ueno T, Hazue R, Hasegawa J, Sekine A, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Suwabe T, Sawa N, Fujii T, Hara S, Ohashi K, Takaichi K, and Ubara Y. Prognostic value of tubulointerstitial lesions, urinary N-acetyl-β-d-glucosaminidase, and urinary β2-microglobulin in patients with type 2 diabetes and biopsy-proven diabetic nephropathy. Clin J Am Soc Nephrol 2016. Doi: 10.2215/CJN.04980515.
64. Morris MS. Homocysteine and Alzheimer's disease. Lancet Neurol 2: 425-428, 2003.
65. Módis K, Coletta C, Erdélyi K, Papapetropoulos A, and Szabo C. Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics. FASEB J 27: 601-611, 2013.
66. Mrozikiewicz PM, Bogacz A, Omielańczyk M, Wolski H, Bartkowiak-Wieczorek J, Grześkowiak E, Czerny B, Drews K, and Seremak-Mrozikiewicz A. The importance of rs1021737 and rs482843 polymorphisms of cystathionine gamma-lyase in the etiology of preeclampsia in the Caucasian population. Ginekol Pol 86: 119-125, 2015.
67. Mustafa AK, Gadalla MM, Sen N, Kim S, MuW, Gazi SK, Barrow RK, Yang G, Wang R, and Snyder SH. H2S signals through protein S-sulfhydration. Sci Signal 2: ra72, 2009.
68. Mustafa AK, Sikka G, Gazi SK, Steppan J, Jung SM, Bhunia AK, Barodka VM, Gazi FK, Barrow RK, Wang R, Amzel LM, Berkowitz DE, and Snyder SH. Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ Res 109: 1259-1268, 2011.
69. Nagy P and Winterbourn CC. Rapid reaction of hydrogen sulfide with the neutrophil oxidant hypochlorous acid to generate polysulfides. Chem Res Toxicol 23: 1541-1543, 2010.
70. 2S signalling through protein sulfhydration and beyond. Nat Rev Mol Cell Biol 13: 499-507, 2012.
71. Perna AF, Luciano MG, Ingrosso D, Pulzella P, Sepe I, Lanza D, Violetti E, Capasso R, Lombardi C, and De Santo NG. Hydrogen sulphide-generating pathways in haemodialysis patients: a study on relevant metabolites and transcriptional regulation of genes encoding for key enzymes. Nephrol Dial Transplant 24: 3756-3763, 2009.
72. Pushpakumar S, Kundu S, and Sen U. Endothelial dysfunction: the link between homocysteine and hydrogen sulfide. Curr Med Chem 21: 3662-3672, 2014.
73. Salloum FN, Chau VQ, Hoke NN, Abbate A, Varma A, Ockaili RA, Toldo S, and Kukreja RC. Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase G-dependent generation of hydrogen sulfide. Circulation 120: S31-S36, 2009.
74. Sataranatarajan K, Mariappan MM, Lee M-J, Feliers D, Choudhury GG, Barnes JL, and Kasinath BS. Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin. Am J Pathol 171: 1733-1742, 2007.
75. Sedeek M, Gutsol A, Montezano AC, Burger D, Nguyen Dinh Cat A, Kennedy CRJ, Burns KD, Cooper ME, Jandeleit-Dahm K, Page P, Szyndralewiez C, Heitz F, Hebert RL, and Touyz RM. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of type 2 diabetes. Clin Sci 124: 191-202, 2013.
76. Sen N, Paul BD, Gadalla MM, Mustafa AK, Sen T, Xu R, Kim S, and Snyder SH. Hydrogen sulfide-linked sulfhydration of NF-κB mediates its antiapoptotic actions. Mol Cell 45: 13-24, 2012.
77. Sen U, Basu P, Abe OA, Givvimani S, Tyagi N, Metreveli N, Shah KS, Passmore JC, and Tyagi SC. Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. Am J Physiol Renal Physiol 297: F410-F419, 2009.
78. Sen U, Munjal C, Qipshidze N, Abe O, Gargoum R, and Tyagi SC. Hydrogen sulfide regulates homocysteine-mediated glomerulosclerosis. Am J Nephrol 31: 442-455, 2010.
79. Sen U, Sathnur PB, Kundu S, Givvimani S, Coley DM, Mishra PK, Qipshidze N, Tyagi N, Metreveli N, and Tyagi SC. Increased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia. Am J Physiol Cell Physiol 303: C41-C51, 2012.
80. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, Falkner B, and Goldstein BJ. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118: 1645-1656, 2008.
81. Shibuya N, Koike S, Tanaka M, Ishigami-Yuasa M, Kimura Y, Ogasawara Y, Fukui K, Nagahara N, and Kimura H. A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells. Nat Commun 4: 1366, 2013.
82. Shibuya N, Mikami Y, Kimura Y, Nagahara N, and Kimura H. Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J Biochem 146: 623-626, 2009.
83. Singh S, Padovani D, Leslie RA, Chiku T, and Banerjee R. Relative contributions of cystathionine beta-synthase and gamma-cystathionase to H2S biogenesis via alternative transsulfuration reactions. J Biol Chem 284: 22457-22466, 2009.
84. Sonenberg N and Hinnebusch AG. New modes of translational control in development, behavior, and disease. Mol Cell 28: 721-729, 2007.
85. Song K, Wang F, Li Q, Shi Y-B, Zheng H-F, Peng H, Shen H-Y, Liu C-F, and Hu L-F. Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy. Kidney Int 85: 1318-1329, 2014.
86. Stipanuk MH and Beck PW. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem J 206: 267-277, 1982.
87. Stubbert D, Prysyazhna O, Rudyk O, Scotcher J, Burgoyne JR, and Eaton P. Protein kinase G Iα oxidation paradoxically underlies blood pressure lowering by the reductant hydrogen sulfide. Hypertension 64: 1344-1351, 2014.
88. Suzuki K, Olah G, Módis K, Coletta C, Kulp G, Gerö D, Szoleczky P, Chang T, Zhou Z, Wu L, Wang R, Papapetropoulos A, and Szabo C. Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci U S A 108: 13829-13834, 2011.
89. Tan Z, Shi Y, Yan Y, Liu W, Li G, and Li R. Impact of endogenous hydrogen sulfide on toll-like receptor pathway in renal ischemia/reperfusion injury in rats. Ren Fail 37: 727-733, 2015.
90. 2S is an endothelium-derived hyperpolarizing factor. Antioxid Redox Signal 19: 1634-1646, 2013.
91. Testai L, D'Antongiovanni V, Piano I, Martelli A, Citi V, Duranti E, Virdis A, Blandizzi C, Gargini C, Breschi MC, and Calderone V. Different patterns of H2S/NO activity and crosstalk in the control of the coronary vascular bed under normotensive or hypertensive conditions. Nitric Oxide 47: 25-33, 2015.
92. Thallas-Bonke V, Jha JC, Gray SP, Barit D, Haller H, Schmidt HHHW, Coughlan MT, Cooper ME, Forbes JM, and Jandeleit-Dahm KAM. Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy. Physiol Rep 2: e12192, 2014.
93. Wallace JL and Wang R. Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter. Nat Rev Drug Discov 14: 329-345, 2015.
94. Wang K, Ahmad S, Cai M, Rennie J, Fujisawa T, Crispi F, Baily J, Miller MR, Cudmore M, Hadoke PWF, Wang R, Gratacós E, Buhimschi IA, Buhimschi CS, and Ahmed A. Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. Circulation 127: 2514-2522, 2013.
95. Wang Y, Shi S, Dong S, Wu J, Song M, Zhong X, and Liu Y. Sodium hydrosulfide attenuates hyperhomocysteinemia rat myocardial injury through cardiac mitochondrial protection. Mol Cell Biochem 399: 189-200, 2015.
96. Whiteman M, Gooding KM, Whatmore JL, Ball CI, Mawson D, Skinner K, Tooke JE, and Shore AC. Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide. Diabetologia 53: 1722-1726, 2010.
97. Xia M, Chen L, Muh RW, Li P-L, and Li N. Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys. J Pharmacol Exp Ther 329: 1056-1062, 2009.
98. 2S donor sodium hydrosulfide in diabetic nephropathy. Clin Exp Nephrol 17: 32-40, 2013.
99. Yang G, Tang G, Zhang L, Wu L, and Wang R. The pathogenic role of cystathionine γ-lyase/hydrogen sulfide in streptozotocin-induced diabetes in mice. Am J Pathol 179: 869-879, 2011.
100. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S, Snyder SH, and Wang R. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322: 587-590, 2008.
101. Yuan P, Xue H, Zhou L, Qu L, Li C, Wang Z, Ni J, Yu C, Yao T, Huang Y, Wang R, and Lu L. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide. Nephrol Dial Transplant 26: 2119-2126, 2011.
102. Zhang H, Zhang A, Guo C, Shi C, Zhang Y, Liu Q, Sparatore A, and Wang C. S-diclofenac protects against doxorubicin-induced cardiomyopathy in mice via ameliorating cardiac gap junction remodeling. PLoS One 6: e26441, 2011.
103. Zhang J, Chen S, Liu H, Zhang B, Zhao Y, Ma K, Zhao D, Wang Q, Ma H, and Zhang Z. Hydrogen sulfide prevents hydrogen peroxide-induced activation of epithelial sodium channel through a PTEN/PI(3,4,5)P3 dependent pathway. PLoS One 8: e64304, 2013.
104. Zhao W and Wang R. H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 283: H474-H480, 2002.
105. Zhong G, Chen F, Cheng Y, Tang C, and Du J. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J Hypertens 21: 1879-1885, 2003.
106. Zhou X, Feng Y, Zhan Z, and Chen J. Hydrogen sulfide alleviates diabetic nephropathy in a streptozotocin-induced diabetic rat model. J Biol Chem 289: 28827-28834, 2014.